US regulators approved
The
Moderna shares rose as much as 2.2% in premarket trading in New York on Thursday.
Since the pandemic, pediatric doses of Covid shots from Moderna and
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.